IDEAS home Printed from https://ideas.repec.org/a/rom/mrpase/v13y2021i4p5-16.html
   My bibliography  Save this article

Differences In Biosimilars Approval Between The Usa And European Union

Author

Listed:
  • Benjamin FRANCO

    (Bucharest University of Economic Studies, Romania)

  • Silviu-Cristian BANACU

    (Bucharest University of Economic Studies, Romania)

Abstract

Biosimilar reviews and approvals have significant structural differences that contrast Europe and the United states. Regulatory processes and market subtleties create a divergence of the markets. This paper will review market differences between Europe and the USA and evaluate strengths and weaknesses between the two systems. The study explores the differences in terms of the approval times for the biosimilars, the differences in intellectual property rights, the effects that expiring and extended biologic patents have on the entry of biosimilars, and the effects that lawsuits have on the approval process. There are various examples from Europe that the USA could consider embracing that would lead to lower biosimilar and biologics pricing. Particularly, policy changes aimed to encourage the healthcare industry to help educate the public to address false notions of biosimilar’s effectiveness and safety as well as increasing incentives for prescriptions to include biosimilars in lieu of biologics to aid in equalizing market pricing.

Suggested Citation

  • Benjamin FRANCO & Silviu-Cristian BANACU, 2021. "Differences In Biosimilars Approval Between The Usa And European Union," Management Research and Practice, Research Centre in Public Administration and Public Services, Bucharest, Romania, vol. 13(4), pages 5-16, December.
    • Handle: RePEc:rom:mrpase:v:13:y:2021:i:4:p:5-16
    as

    Download full text from publisher

    File URL: https://mrp.ase.ro/no134/f1.pdf
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:rom:mrpase:v:13:y:2021:i:4:p:5-16. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Colesca Sofia (email available below). General contact details of provider: https://edirc.repec.org/data/ccasero.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.